REGULUS THERAPEUTICS INC (RGLS)
US75915K3095 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 70K | 6.83M 9,657.14% | 10.01M 46.56% | -100.00% | 90.168M | 342.28M 279.60% | 700.62M 104.69% | 1.393B 98.82% | 258.06M -81.47% | ||||||
| EBITDA YoY % growth | -44.5M 34.18% | -15.9M 64.27% | -13.69M 13.90% | N/A -99.85% | N/A -2.78% | -31.314M -9.82% | -50.898M -64.81% | -62.832M -23.45% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -46.76M 33.32% | -16.83M 64.01% | -14.16M 15.86% | -28.069M -96.47% | -29.407M -1.51% | -31.569M -10.16% | -51.837M -66.63% | -71.564M -38.06% | -87.344M -22.05% | -29.586M 66.13% | 192.63M 751.08% | 507.69M 163.56% | 1.122B 121.00% | 103.02M -90.82% | |
| Operating Margin | -66,800.00% | -246.41% | -141.46% | N/A | N/A | N/A | N/A | N/A | N/A | -32.81% | 56.28% | 72.46% | 80.55% | 39.92% | |
| EPS YoY % growth | -55.20 58.56% | -11.00 80.07% | -5.50 50.00% | -3.33 40.00% | -1.80 42.42% | -1.62 16.32% | -0.87 45.36% | -1.26 -45.40% | -1.57 -24.36% | -1.35 13.96% | 0.64 147.55% | 3.75 484.13% | 8.93 137.77% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.21 46.45% | -0.24 17.34% | -0.25 -48.50% | -0.27 -29.93% | -0.30 -39.29% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -14.71M -77.23% | -15.555M -76.24% | -15.657M -27.71% | -16.32M -7.30% | -16.524M -12.33% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.21 47.50% | -0.17 | -0.04 | -21.11% |
| Q2 2024 Q2Q % growth | -0.17 54.05% | -0.15 | -0.02 | -13.63% |
| Q1 2024 Q2Q % growth | -0.29 30.95% | -0.23 | -0.06 | -27.78% |
| Q4 2023 Q2Q % growth | -0.40 | -0.40 | 0.00 | 0.72% |
| Q3 2023 Q2Q % growth | -0.40 20.00% | -0.40 | 0.00 | 1.14% |
| Q2 2023 Q2Q % growth | -0.37 26.00% | -0.42 | 0.05 | 11.53% |
| Q1 2023 Q2Q % growth | -0.42 16.00% | -0.45 | 0.03 | 5.70% |
| Q4 2022 Q2Q % growth | -0.40 42.86% | -0.52 | 0.12 | 23.11% |
| Q3 2022 Q2Q % growth | -0.50 50.00% | -0.50 | 0.00 | -0.04% |
| Q2 2022 Q2Q % growth | -0.50 37.50% | -0.49 | -0.01 | -1.07% |
| Q1 2022 Q2Q % growth | -0.50 37.50% | -0.54 | 0.04 | 8.08% |
| Q4 2021 Q2Q % growth | -0.70 -133.33% | -0.68 | -0.02 | -2.94% |
| Q3 2021 Q2Q % growth | -1.00 -150.00% | -0.79 | -0.21 | -26.50% |
| Q2 2021 Q2Q % growth | -0.80 65.22% | -0.82 | 0.02 | 1.96% |
| Q1 2021 Q2Q % growth | -0.80 68.00% | -0.92 | 0.12 | 12.85% |
| Q4 2020 Q2Q % growth | -0.30 86.96% | -1.43 | 1.13 | 78.99% |
| Q3 2020 Q2Q % growth | -0.40 84.62% | -2.12 | 1.72 | 81.10% |
| Q2 2020 Q2Q % growth | -2.30 23.33% | -1.10 | -1.20 | -109.76% |
| Q1 2020 Q2Q % growth | -2.50 19.35% | -1.22 | -1.28 | -104.25% |
| Q4 2019 Q2Q % growth | -2.30 | -2.45 | 0.15 | 6.05% |
| Q3 2019 Q2Q % growth | -2.60 | -2.68 | 0.08 | 2.89% |
| Q2 2019 Q2Q % growth | -3.00 | -5.54 | 2.54 | 45.87% |
| Q1 2019 Q2Q % growth | -3.10 | -11.73 | 8.63 | 73.57% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2021 Q2Q % growth | -100.00% | % | ||
| Q3 2021 Q2Q % growth | -100.00% | 4.59K | -4.59K | -100.00% |
| Q2 2021 Q2Q % growth | 6.12K | -6.12K | -100.00% | |
| Q1 2021 Q2Q % growth | -100.00% | 18.36K | -18.36K | -100.00% |
| Q4 2020 Q2Q % growth | 5M 24,900.00% | 18.36K | 4.982M | 27,133.12% |
| Q3 2020 Q2Q % growth | 5M 24,900.00% | 346.117K | 4.654M | 1,344.60% |
| Q2 2020 Q2Q % growth | -100.00% | 3.406M | -3.406M | -100.00% |
| Q1 2020 Q2Q % growth | 10K -99.85% | 3.406M | -3.396M | -99.71% |
| Q4 2019 Q2Q % growth | 20K | 6.12K | 13.88K | 226.80% |
| Q3 2019 Q2Q % growth | 20K | 6.12K | 13.88K | 226.80% |
| Q2 2019 Q2Q % growth | 20K | 1.284M | -1.264M | -98.44% |
| Q1 2019 Q2Q % growth | 6.78M | 9.18K | 6.771M | 73,756.21% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -52.17% | 0% | -12.8% |
| Revenue | N/A | N/A | N/A | N/A |